Skip to main content
. 2017 Jul 5;7:4657. doi: 10.1038/s41598-017-04730-5

Figure 3.

Figure 3

Effect of FFAR1 and fatty acid β-oxidation on basal glucagon (panels A,G), insulin (panels B,H) and somatostatin (panels C,I) secretion and content (panels D-F,F). Human islets were cultured for 1 day with or with out FFAR1 agonists; TAK-875, GW9508, TUG-499 in comparison to palmitate (black bars) (panel A–C), and with palmitate with and without ANT825 and/or etomoxir (panel G–I). Results show mean ± SEM and are from n = 5 donor experiments. #P < 0.05 vs. palmitate, and & vs. palmitate + etomoxir.